Eli Lilly And Company (LLY): Today's Featured Health Care Laggard

Eli Lilly and Company ( LLY) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 0.3%. By the end of trading, Eli Lilly and Company fell $0.54 (-1.1%) to $51.00 on light volume. Throughout the day, 3,994,641 shares of Eli Lilly and Company exchanged hands as compared to its average daily volume of 5,337,600 shares. The stock ranged in price between $50.80-$51.79 after having opened the day at $51.55 as compared to the previous trading day's close of $51.54. Other companies within the Health Care sector that declined today were: Mast Therapeutics ( MSTX), down 37.2%, Thermogenesis Corporation ( KOOL), down 15.4%, Addus Homecare Corporation ( ADUS), down 15.3% and Regulus Therapeutics ( RGLS), down 12.0%.

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. Eli Lilly and Company has a market cap of $58.0 billion and is part of the drugs industry. Shares are up 4.3% year to date as of the close of trading on Monday. Currently there are 6 analysts that rate Eli Lilly and Company a buy, 2 analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Eli Lilly and Company as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, increase in net income, largely solid financial position with reasonable debt levels by most measures, notable return on equity and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Aratana Therapeutics ( PETX), up 15.9%, Ventrus Biosciences ( VTUS), up 10.4%, Uroplasty ( UPI), up 10.2% and Senesco Technologies ( SNTI), up 10.0% , were all gainers within the health care sector with Community Health Systems ( CYH) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Eli Lilly Still Looking for Lower Prices

Is Lilly Headed for the Valley?

Walmart, With Extra $10M Fund, Is Among 7 Giving for Hurricane Irma Relief